Pharmaceuticals: US Generic Growth to Stay, Selective on Structural Play
The pharmaceutical sector, emerging from the volatility of the past two post-pandemic and geopolitically tumultuous years, is now on a recovery...
224 Views
Quiddity Leaderboard BSE/SENSEX Jun 24: Wipro SENSEX Deletion Possible
Wipro could be deleted from the SENSEX index in June 2024 and Coal India could become the replacement. There could be around three days of volume...
456 Views
Indian Generic Pharmaceutical Companies: US Momentum to Continue Amid Favorable Sector Tailwinds
Indian pharma companies saw strong U.S. revenue growth in H1FY24 due to better pricing, drug shortages, and new launches. With robust pipeline and...
401 Views
Alkem Laboratories Ltd (ALKEM IN): Further Upside on Card on US Business and Margin Improvement
Alkem is looking at high-single-digit growth in dollar terms from US business in FY24. FY24 gross margin guidance is 59.0–59.5%, backed by lower...
403 Views
Pharma Sector: Q2FY24 Review
In Q2FY24, the Pharma Coverage universe posted robust revenue growth of 14.3%/1.7% YoY/QoQ on account of volume rampup, new launches (especially...
304 Views